Beyond Air, Inc.: ARMISTICE CAPITAL, LLC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Armistice Capital LLC disclosed a stake exceeding 5% in Beyond Air, Inc. via a Schedule 13G filing with the SEC (accession 0001172661-26-005262). The filing signals that the investment firm has crossed the threshold requiring public disclosure of its position in the medical device maker. The exact share count and percentage were not specified in the headline disclosure. The move makes Armistice a notable institutional holder in Beyond Air, whose shares are closely watched given the company's small-cap profile. Investors will watch for further 13G amendments or 13D filings that could indicate activist intent or changes in the position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Armistice Capital, LLC, Beyond Air, Inc.